Ayşegül Özerdem, MD, PhD

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota.

  • 3Articles
  • 56.6KReads
  • 2011–2026Active
  • 19Collaborators
  • 46Citations

About

Ayşegül Özerdem, MD, PhD is affiliated with Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota. Ayşegül Özerdem has authored or co-authored 3 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 2011 and 2026. Their work focuses on Depression (MDD) and Bipolar Disorder.

Publications

JCP
Next-Step Treatment Options for Treatment-Resistant Depression
Consensus Statement

Next-Step Treatment Options for Treatment-Resistant Depression

January 21, 2026

Strong consensus emerged for augmentation with second-generation antipsychotics, TMS, and ketamine/esketamine in the base vignette. Preferences shifted to include non-augmentative antidepressants and ECT based on patient characteristics.
, , , et al
JCP
When and How to Use Lithium Augmentation for MDD
ASCP Corner

When and How to Use Lithium Augmentation for MDD

March 8, 2023

With its antisuicidal effect and low cost, lithium can be an effective alternative to other MDD augmentation strategies when antidepressants are not enough.
, ,
JCP
Article

International Consensus Group on Depression Prevention in Bipolar Disorder

October 24, 2011

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe